Get started
Japan 225 CFDJapan 225 CFDJapan 225 CFD

Japan 225 CFD

No trades
OverviewNewsCommunitySeasonals

What traders are saying


Join the conversation. Discover trade ideas, share insights, and see how others read the market.
Trade ideasMinds
manasiparulekar8
NIKKEI Nikkei edges higher because of the yen strengthens.
Japan's Nikkei Index rose on morning because of optimism over easing USA tariffs supported despite pressure from a strengthening yen. USDJPY fell to 155.16 amid expectations of BOJ 25 bps rate hike. A stronger yen could weaken oversea earnings and valuations.
Snapshot
viktorlevov
JP225 keep selling Nikkei for the target of 33990, it gonna go down
PHDCAPITAL
NI225 After 7 retests over 20+ years, the #NIKKEI300 Index has rallied 75%. Now, an even more intriguing chart pattern is emerging: the #NIKKEI225 Index has achieved a massive breakout above its 1989 closing high, ending an almost 35-year consolidation.

Key points:

• Nikkei 225 breaks above 1989 closing high
• 35-year base breakout pattern
• Potential target: 70,000+
• Signals start of a new Japanese bull market

This rare, multi-decade breakout suggests significant upside potential for Japanese equities. With economic reforms, improved corporate governance, and global investors refocusing on Japan, we may be witnessing the start of a powerful bull run.

Investors should watch closely as this historic move unfolds. The Land of the Rising Sun may once again become a beacon for global markets.

For regular updates and BUY/SELL/HOLD stock advisory, join: phdcapital.in/phd-capital-research-subscriptions/

#JapaneseStocks #BullMarket #TechnicalAnalysis #InvestmentStrategy

Disclaimer: This post is for educational purposes only and not a recommendation. We are a SEBI registered Research Analyst (SEBI No. INH000016126 - Non-individual). I study over 1000+ technical charts regularly, which is why I share these charts for investor education. We can provide BUY/SELL/HOLD recommendations only after you subscribe to our paid advisory service. We do not offer any personalized free trials as per regulatory restrictions. Please do not ask for free trials.